ECP 2023 Final Programme

195 ECP 2023 Dublin © 2023 Bristol-Myers Squibb Company. NO-GB-2300192 July/23 Tuesday, 12 September 2023  |  13:00–14:30 BST PD-L1: Proficiency Testing Programs and External Quality Assessment ECP 2023 Industry Satellite Symposium 13:00–13:10 Welcome and introduction Professor Arndt Hartmann – Meeting Chair University Erlangen-Nürnberg, Erlangen, Germany 13:10–13:30 The state of PD-L1 testing in NSCLC: what does the external quality assessment data show? UK NEQAS perspective Andrew Dodson UK NEQAS, London, United Kingdom 13:30–13:50 The state of PD-L1 testing in gastric and bladder cancer: what does the external quality assessment data show? The Quality in Pathology (QuIP) GmbH perspective Professor Arndt Hartmann University Erlangen-Nürnberg, Erlangen, Germany 13:50–14:10 NordiQC: results and experiences learned for PD-L1 biomarker testing Søren Nielsen NordiQC, Aalborg University Hospital, Aalborg, Denmark 14:10–14:30 Q&A All faculty This Industry-Sponsored Symposium Is a Medical Education Activity That Is Organized and Funded by the Medical Department of Bristol Myers Squibb.